Results 161 to 170 of about 12,730,863 (301)
Abstract Background Allogeneic hematopoietic stem cell transplantation (HSCT) is a treatment primarily for hematological malignancies. Infections, relapse, and graft versus host disease (GvHD) are some of the most common adverse events following HSCT. We aimed to evaluate whether the lymphocyte function of the stem cell graft was associated with these ...
Anna Söderström +8 more
wiley +1 more source
Toxicity of Cytarabine Intravenous Constant Rate Infusion in Cats With Lymphoma
ABSTRACT Cytarabine intravenous constant rate infusion (IV CRI) toxicity in cats with lymphoma has not been well documented. We aimed to assess toxicities following cytarabine IV CRI as a single‐agent or within a multiagent protocol in cats with lymphoma. Medical records of cats with lymphoma treated with cytarabine IV CRI, with documented dose, route,
Rachel Hanford +5 more
wiley +1 more source
Integrative genomic analysis of B-lymphoblastic lymphoma with intrachromosomal amplification of chromosome 21. [PDF]
Sharma R +8 more
europepmc +1 more source
Case Report: T‐Lymphoblastic Leukemia in a Dog With Erythrophagia
ABSTRACT A 2‐year‐old male German Shepherd dog was presented with progressive weight loss, lethargy, and hyporexia. Hematologic analysis revealed a moderate macrocytic normochromic anemia and moderate thrombocytopenia. Additionally, a pronounced leukocytosis was observed, characterized by 33% large lymphoid cells, marked neutrophilia with a significant
Francisca B. Lang +7 more
wiley +1 more source
ABSTRACT Background Acute myeloid leukemia (AML) is difficult to distinguish from lymphoblastic leukemia or lymphoma (LL) on morphologic features alone. Therapeutic approaches for AML versus LL differ, and immediate therapy is often needed due to patient illness and rapid disease progression.
Mayzie Miller +4 more
wiley +1 more source
B-lymphoblastic leukemia/lymphoma with an unusual appendiceal involvement [PDF]
Narittee Sukswai, Duangpen Thirabanjasak
openaire +2 more sources

